Edition:
United States

Cara Therapeutics Inc (CARA.OQ)

CARA.OQ on NASDAQ Stock Exchange Global Market

19.06USD
4:00pm EDT
Change (% chg)

$-0.20 (-1.04%)
Prev Close
$19.26
Open
$19.19
Day's High
$19.35
Day's Low
$18.70
Volume
245,691
Avg. Vol
309,700
52-wk High
$22.28
52-wk Low
$11.12

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 0.00 -0.513
FY 2017 Dec '17 0.00 0.360
Sep '17 0.00 -0.382
Jun '17 0.00 -0.288
Mar '17 0.91 -0.813
FY 2016 Dec '16 0.00 -0.805
Sep '16 0.00 -0.423
Jun '16 0.08 -0.479
Mar '16 0.01 -0.392
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-18 8 0.03 0.25 0.00 0.00
Quarter Ending Dec-18 8 0.97 5.00 0.00 3.45
Year Ending Dec-18 8 7.47 55.00 0.00 2.38
Year Ending Dec-19 7 3.42 11.10 0.00 4.79
Earnings (per share)
Quarter Ending Sep-18 8 -0.54 -0.47 -0.65 -0.45
Quarter Ending Dec-18 8 -0.55 -0.33 -0.65 -0.32
Year Ending Dec-18 8 -1.92 -0.28 -2.35 -2.28
Year Ending Dec-19 8 -2.26 -1.83 -2.51 -2.07
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 214.53 33.05
P/E High - Last 5 Yrs. -- 284.38 47.17
P/E Low - Last 5 Yrs. -- 96.91 24.95
Beta 2.97 0.76 0.81
Price to Sales (TTM) -- 254.39 8.10
Price to Book (MRQ) 8.73 21.00 4.20
Price to Tangible Book (MRQ) 8.99 27.24 6.22
Price to Cash Flow (TTM) -- 130.02 22.23
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.36 1.74
Dividend Yield - 5 Year Avg -- 0.21 1.46
Dividend 5 Year Growth Rate -- 2.25 -6.34
Payout Ratio(TTM) -- 83.66 47.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -100.00 33.06 4.76
Sales (TTM) vs TTM 1 Yr. Ago -100.00 147.32 12.20
Sales - 5 Yr. Growth Rate -5.20 30.74 7.68
EPS (MRQ) vs Qtr. 1 Yr. Ago 36.92 -78.41 49.25
EPS (TTM) vs TTM 1 Yr. Ago 67.33 -- --
EPS - 5 Yr. Growth Rate -- 46.75 7.98
Capital Spending - 5 Yr. Growth Rate -- 42.59 7.61

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.72 2.56
Current Ratio (MRQ) 11.46 6.63 3.63
LT Debt to Equity (MRQ) 2.30 24.37 13.18
Total Debt to Equity (MRQ) 2.30 28.57 17.32
Interest Coverage (TTM) -- -156.06 35.18

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 55.96 55.27
Gross Margin - 5 Yr. Avg. -- 53.49 53.21
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -787.38 -180.79 15.63
Operating Margin (TTM) -- -952.42 -0.59
Operating Margin - 5 Yr. Avg. -809.30 -194.47 10.78
Pre-Tax Margin (TTM) -- -846.49 1.29
Pre-Tax Margin - 5 Yr. Avg. -817.93 -199.31 10.90
Net Profit Margin (TTM) -- -837.92 -2.01
Net Profit Margin - 5 Yr. Avg. -681.46 -197.08 7.26
Effective Tax Rate (TTM) -- 14.85 20.80
Effective Tax Rate - 5 Yr. Avg. -- 19.02 24.29

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,390,416 736,883,287
Net Income/Employee (TTM) -723,649 -1,131,911 85,936,826
Receivable Turnover (TTM) -- 17.85 5.95
Inventory Turnover (TTM) -- 2.85 3.69
Asset Turnover (TTM) 0.00 0.48 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -43.21 -2.22 10.35
Return on Assets - 5 Yr. Avg. -45.29 2.95 11.02
Return on Investment (TTM) -51.22 -3.67 13.17
Return on Investment - 5 Yr. Avg. -50.46 2.77 14.24
Return on Equity (TTM) -52.83 -5.61 15.10
Return on Equity - 5 Yr. Avg. -80.02 -4.39 15.57
  1 Year 3 Year 5 Year
Sales % 959.30 -34.06 -5.20
EPS (TTM) % 50.84 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cara Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 14.23 12.01 99 39
13 Week 56.08 49.88 99 61
26 Week 54.82 54.47 99 70
52 Week 23.15 8.63 99 84
YTD 57.35 50.01 99 85
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 55.24%
# of Holders: 165
Total Shares Held: 18,063,219
3 Mo. Net Change: -10,639
# New Positions: 2
# Closed Positions: 2
# Increased Positions: 5
# Reduced Positions: 5
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.